Drug Companies Spurned by Supreme Court on Price Negotiation Law

The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on top-selling treatments.

Read the article here

Lisätietoja Toimitus

Toimitus

Katso myös

Lilly Rebuffed by Supreme Court on $194 Million Medicaid Award

The US Supreme Court let stand a $194 million award against Eli Lilly & Co. …